{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:17:16Z","timestamp":1778239036178,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejpb.2016.08.012","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T06:41:12Z","timestamp":1472625672000},"page":"24-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan"],"prefix":"10.1016","volume":"109","author":[{"given":"Ze","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.08.012_b0005","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2217\/nnm.14.156","article-title":"Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery","volume":"9","author":"Pavot","year":"2014","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.ejpb.2016.08.012_b0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B914943K","article-title":"Designing polymeric particles for antigen delivery","volume":"40","author":"De Koker","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejpb.2016.08.012_b0015","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.addr.2011.05.021","article-title":"Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations","volume":"63","author":"Hamdy","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.08.012_b0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/adhm.201200268","article-title":"Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective","volume":"2","author":"Leleux","year":"2013","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejpb.2016.08.012_b0025","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.addr.2013.05.007","article-title":"Targeting C-type lectin receptors with multivalent carbohydrate ligands","volume":"65","author":"Lepenies","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2016.08.012_b0030","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1016\/j.biomaterials.2012.02.036","article-title":"Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN","volume":"33","author":"Cruz","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.08.012_b0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/1061186X.2010.499463","article-title":"Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles","volume":"19","author":"Ghotbi","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2016.08.012_b0040","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s11095-011-0459-9","article-title":"Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles","volume":"28","author":"Hamdy","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.08.012_b0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jconrel.2011.12.039","article-title":"Towards tailored vaccine delivery: needs, challenges and perspectives","volume":"161","author":"Amorij","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.08.012_b0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.nantod.2014.04.011","article-title":"Intracellular delivery of nanomaterials: how to catch endosomal escape in the act","volume":"9","author":"Martens","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.ejpb.2016.08.012_b0055","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.biomaterials.2008.10.034","article-title":"The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal nanoparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid)","volume":"30","author":"Heffernan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.08.012_b0060","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1021\/nn305466z","article-title":"PH-Responsive nanoparticles vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides","volume":"7","author":"Wilson","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2016.08.012_b0065","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1002\/anie.201102852","article-title":"Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments","volume":"50","author":"Ke","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejpb.2016.08.012_b0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijpharm.2015.10.004","article-title":"Stabilization and immune response of HBsAg encapsulated within poly(lactic-co-glycolic acid) microspheres using HSA as a stabilizer","volume":"496","author":"Xu","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.012_b0075","first-page":"895","article-title":"Fluorescence quenching method for the determination of chitosan with alizarin red S","volume":"23","author":"Gao","year":"2003","journal-title":"Spectrosc. Spect. Anal."},{"key":"10.1016\/j.ejpb.2016.08.012_b0080","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/mp400597z","article-title":"Enhanced humoral and cell-mediated immune responses generated by cationic polymer-coated PLA microspheres with adsorbed HBsAg","volume":"11","author":"Chen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.012_b0085","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.08.012_b0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/mp100255c","article-title":"Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine","volume":"8","author":"Thomas","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.012_b0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2014.05.003","article-title":"Chitosan in nasal delivery systems for therapeutic drugs","volume":"190","author":"Casettari","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.08.012_b0100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejpb.2013.06.017","article-title":"Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity","volume":"85","author":"Pawar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.08.012_b0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ejpb.2016.08.012_b0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biomaterials.2015.02.044","article-title":"Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles","volume":"52","author":"Chu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2016.08.012_b0115","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1517\/14712598.4.12.1953","article-title":"Mannose receptor targeted vaccines","volume":"4","author":"Keler","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ejpb.2016.08.012_b0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2007.10.011","article-title":"Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats","volume":"125","author":"Wijagkanalan","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2016.08.012_b0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrm2820","article-title":"Sensors and regulators of intracellular pH","volume":"11","author":"Casey","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejpb.2016.08.012_b0130","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1021\/nn5066793","article-title":"PH-responsive Poly(D, L-lactic-co-glycolic acid) nanoparticles with rapid antigen release behavior promote immune response","volume":"9","author":"Liu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2016.08.012_b0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00602-0","article-title":"Clearance characteristics of chitosan based formulation in the sheep nasal cavity","volume":"217","author":"Soane","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.08.012_b0140","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0168-8278(03)00152-1","article-title":"Hepatitis B vaccines","volume":"39","author":"Shouval","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejpb.2016.08.012_b0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2010.07.015","article-title":"Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling","volume":"33","author":"Deenick","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ejpb.2016.08.012_b0150","doi-asserted-by":"crossref","first-page":"15460","DOI":"10.1073\/pnas.0707331104","article-title":"Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation","volume":"104","author":"Obst","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejpb.2016.08.012_b0155","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.vaccine.2006.01.011","article-title":"Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally","volume":"24","author":"Jaganathan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2016.08.012_b0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2011.01.045","article-title":"Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen","volume":"408","author":"Saini","year":"2011","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116304659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116304659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T22:23:00Z","timestamp":1536445380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116304659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":32,"alternative-id":["S0939641116304659"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.08.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}